Importance of Viruses in Exacerbations of Chronic Obstructive Pulmonary Disease (COPD). Could Change its Behavior During the SARS-COV-2 (COVID-19) pandemic?

Importancia de los virus en las exacerbaciones de Enfermedad Pulmonar Obstructiva Crónica (EPOC). ¿Podría cambiar su comportamiento durante la pandemia de SARS-COV-2 (COVID-19)?;
Importância dos vírus nas exacerbações da Doença Pulmonar Obstrutiva Crônica (DPOC). Poderia mudar seu comportamento durante a pandemia de SARS-COV-2 (COVID-19)?

dc.creatorEnciso Bahamón, Luisa Fernanda
dc.creatorBastidas Goyes , Alirio Rodrigo
dc.creatorNarváez Ramírez, Paula Oriana
dc.creatorPerdomo Rodríguez, Laura Sofía
dc.creatorVargas Arcila, Luis Miguel
dc.creatorHincapié Díaz, Gustavo Adolfo
dc.creatorEcheverría González, Claudia Liliana
dc.date2022-08-01
dc.date.accessioned2022-12-15T18:29:12Z
dc.date.available2022-12-15T18:29:12Z
dc.identifierhttps://revistas.unimilitar.edu.co/index.php/rmed/article/view/4873
dc.identifier10.18359/rmed.4873
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5357497
dc.descriptionThe SARS-COV-2 pandemic has raised many questions about the behavior of chronic diseases. Although it is known that patients with significant comorbidities have a higher risk of complications, the behavior of diseases, such as chronic obstructive pulmonary disease (COPD), during the period of the COVID-19 pandemic and quarantine is not known. In this article, a literature review was carried out on the main theoretical aspects to understand the possible interactions between SARS-COV-2 infection and patients with respiratory pathology such as COPD. The main aspects of viral infections and their pathophysiology in the exacerbation of the disease, their inflammatory mechanisms, and the conditions that can increase the risk of infection and severity during the COVID-19 pandemic were reviewed. In addition, aspects related to quarantine and its possible influence on the exacerbation of the disease were explored. Finally, the economic aspects related to the exacerbation and its management associated with the pandemic were explored.en-US
dc.descriptionLa pandemia por SARS-COV-2 ha generado muchos interrogantes sobre el comportamiento de enfermedades crónicas. Si bien se conoce que los pacientes con comorbilidades importantes tienen un mayor riesgo de complicaciones, no se conoce el comportamiento de enfermedades, como la enfermedad pulmonar obstructiva crónica (EPOC), en el período de pandemia y cuarentena por covid-19. En este artículo, se realizó una revisión de la literatura sobre los principales aspectos teóricos para entender las posibles interacciones entre la infección por SARS-COV-2 y pacientes con patología respiratoria como la EPOC. Se revisaron los principales aspectos de las infecciones virales y su fisiopatología en la exacerbación de la enfermedad, sus mecanismos inflamatorios, y las condiciones que pueden aumentar el riesgo de infección y gravedad durante la pandemia por covid-19. Además, se exploraron los aspectos relacionados a la cuarentena y su posible influencia sobre la exacerbación de la enfermedad. Finalmente, se exploraron los aspectos económicos relacionados con la exacerbación y su manejo asociado a la pandemia.es-ES
dc.descriptionA pandemia de SARS-COV-2 tem gerado muitos questionamentos sobre o comportamento das doenças crônicas. Embora se saiba que pacientes com comorbidades significativas apresentam risco aumentado de complicações, o comportamento de doenças como a doença pulmonar obstrutiva crônica (DPOC) não é conhecido. No período de pandemia e quarentena por COVID-19. Neste artigo, foi realizada uma revisão da literatura sobre os principais aspectos teóricos para compreender as possíveis interações entre a infecção por SARS-COV-2 e pacientes com patologia respiratória, como DPOC. Foram revisados os principais aspectos das infecções virais e sua fisiopatologia na exacerbação da doença, seus mecanismos inflamatórios e as condições que podem aumentar o risco de infecção e gravidade durante a pandemia COVID-19. Além disso, foram explorados aspectos relacionados à quarentena e sua possível influência na exacerbação da doença. Por fim, foram explorados os aspectos econômicos relacionados à exacerbação e sua gestão associada à pandemia.pt-BR
dc.formatapplication/pdf
dc.languagespa
dc.publisherUniversidad Militar Nueva Granadaes-ES
dc.relationhttps://revistas.unimilitar.edu.co/index.php/rmed/article/view/4873/5201
dc.relation/*ref*/Guan W, Ni Z, Hu Y, Liang W, P Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. [Internet]. 2020 abr; 382: 1708-120. Disponible en: https://www.nejm.org/doi/full/10.1056/nejmoa2002032 DOI: https://doi.org/10.1056/NEJMoa2002032
dc.relation/*ref*/Disponible en: https://www.paho.org/col/index.php?option=com_content&view=article&id=3331:la-oms-declara-que-el-nuevo-brote-de-coronavirus-es-una-emergencia-de-salud-publica-de-importancia-internacional&Itemid=562
dc.relation/*ref*/Organización Panamericana de la Salud, Organización Mundial de la Salud. Actualización epidemiológica del nuevo coronavirus (covid-19). Washington: OPS, OMS; 2020. Disponible en: https://www.paho.org/sites/default/files/2020-02/2020-feb-14-phe-actualizacion-epi-covid19.pdf
dc.relation/*ref*/Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. [Internet]. 2019 mar; 17(3): 181-192. Disponible en: https://www.nature.com/articles/s41579-018-0118-9 DOI: https://doi.org/10.1038/s41579-018-0118-9
dc.relation/*ref*/Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. covid-19 does not lead to a "typical" acute respiratory distress syndrome. Am J Respir Crit Care Med. [Internet]. 2020 may; 201(10): 1299-1300. DOI: https://doi.org/10.1164/rccm.202003-0817LE
dc.relation/*ref*/Organización Mundial de la Salud. Alocución del director general de la OMS en la rueda de prensa sobre la covid-19 celebrada el 11 de marzo de 2020. [Internet]. Disponible en: https://www.who.int/es/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020
dc.relation/*ref*/Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with covid-19: evidence from meta-analysis. Aging. [Internet]. 2020 abr; 12(7): 6049-6057. Disponible en: https://www.aging-us.com/article/103000/text DOI: https://doi.org/10.18632/aging.103000
dc.relation/*ref*/Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with covid-19: a systematic review and meta-analysis. Arch Acad Emerg Med. [Internet]. 2020 mar; 8(1): e35. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096724/ DOI: https://doi.org/10.1371/journal.pone.0241265 DOI: https://doi.org/10.1371/journal.pone.0241265
dc.relation/*ref*/Guan W, Liang W, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis. Eur Respir J. [Internet]. 2020 may; 55(5): 2000547. Disponible en: https://erj.ersjournals.com/content/55/5/2000547 DOI: https://doi.org/10.1183/13993003.01227-2020
dc.relation/*ref*/Lippi G, Henry BM. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (covid-19). Respir Med. [Internet]. 2020 jun; 167: 105941. Disponible en: https://www.resmedjournal.com/article/S0954-6111(20)30081-0/fulltext DOI: https://doi.org/10.1016/j.rmed.2020.105941
dc.relation/*ref*/Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. [Internet]. 2020 abr; 8(5): 436-438. Disponible en: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30167-3/fulltext DOI: https://doi.org/10.1016/S2213-2600(20)30167-3
dc.relation/*ref*/Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 report). Global Initiative for Chronic Obstructive Lung Disease; 2020. Disponible en: https://goldcopd.org/wp-content/uploads/2019/11/GOLD2020-REPORT-ver1.0wms.pdf
dc.relation/*ref*/Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. [Internet]. 1987 feb; 106(2): 196-204. Disponible en: https://www.acpjournals.org/doi/10.7326/0003-4819-106-2-196 DOI: https://doi.org/10.7326/0003-4819-106-2-196
dc.relation/*ref*/Kurai D, Saraya T, Ishii H, Takizawa H. Virus-induced exacerbations in asthma and COPD. Front Microbiol. [Internet]. 2013 oct; 4: 293. Disponible en: https://www.frontiersin.org/articles/10.3389/fmicb.2013.00293/full DOI: https://doi.org/10.3389/fmicb.2013.00293
dc.relation/*ref*/García-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population-based cohort study. Thorax. [Internet]. 2006 sept; 61(9): 772-778. Disponible en: https://thorax.bmj.com/content/61/9/772 DOI: https://doi.org/10.1136/thx.2006.060145
dc.relation/*ref*/Soler-Cataluña JJ, Martínez-García M, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. [Internet]. 2005 nov; 60(11): 925-931. DOI: https://doi.org/10.1136/thx.2005.040527
dc.relation/*ref*/Hewitt R, Farne H, Ritchie A, Luke E, Johnston S L, Mallia, P. The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma. Ther Adv Respir Dis. [Internet]. 2016; 10(2): 158-174. DOI: https://doi.org/10.1177/1753465815618113
dc.relation/*ref*/Anzueto A. Impact of exacerbations on COPD. EurRespir Rev. [Internet]. 2010 jun; 19(116): 113-118. Disponible en: https://err.ersjournals.com/content/19/116/113 DOI: https://doi.org/10.1183/09059180.00002610
dc.relation/*ref*/Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. [Internet]. 2003 ago; 124(2): 459-67. Disponible en: https://journal.chestnet.org/article/S0012-3692(15)33325-0/fulltext DOI: https://doi.org/10.1378/chest.124.2.459
dc.relation/*ref*/Kherad O, Kaiser L, Bridevaux PO, Sarasin F, Thomas Y, Janssens JP, et al. Upper-respiratory viral infection, biomarkers, and COPD exacerbations. Chest. [Internet]. 2010 oct; 138(4): 896-904. Disponible en: https://journal.chestnet.org/article/S0012-3692(10)60538-7/fulltext DOI: https://doi.org/10.1378/chest.09-2225
dc.relation/*ref*/Spencer S, Jones P. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax. [Internet]. 2003 jul; 58(7): 589-593. Disponible en: https://thorax.bmj.com/content/58/7/589 DOI: https://doi.org/10.1136/thorax.58.7.589
dc.relation/*ref*/Perotin JM, Dury S, Renois F, Deslee G, Wolak A, Du- val V, et al. Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study. J Med Virol. [Internet]. 2013 may; 85(5): 866-873. DOI: https://doi.org/10.1002/jmv.23495
dc.relation/*ref*/Lawrence H, Hunter A, Murray R, Lim WS, McKeever T. Cigarette smoking and the occurrence of influenza - Systematic review. J Infect. [Internet]. 2019 nov; 79(5): 401-406. DOI: https://doi.org/10.1016/j.jinf.2019.08.014
dc.relation/*ref*/Atto B, Eapen-Mathew S, Sharma P, Frey U., Ammit AJ, Markos J, et al. New therapeutic targets for the prevention of infectious acute exacerbations of COPD: role of epithelial adhesion molecules and inflammatory pathways. Clin Sci. [Internet]. 2019 jul133(14): 1663- 1703 DOI: https://doi.org/10.1042/CS20181009
dc.relation/*ref*/Eapen MS, Sharma P, Moodley YP, Hansbro PM, Sohal SS. Dysfunctional immunity and microbial adhesion molecules in smoking-induced pneumonia. Am J Respir Crit Care Med. [Internet]. 2019 ene; 199(2): 250-251. DOI: https://doi.org/10.1164/rccm.201808-1553LE
dc.relation/*ref*/Kurai D, Saraya T, Ishiiand H, Takizawa H. Virus-induced exacerbations in asthma and COPD. Front Microbiol. [Internet]. 2013 oct; 293(4). Disponible en: https://doi.org/10.3389/fmicb.2013.00293
dc.relation/*ref*/Importancia de los virus en las exacerbaciones de Enfermedad Pulmonar Obstructiva Crónica (EPOC). ¿Podría cambiar su comportamiento durante la pandemia de SARS-COV-2 (COVID-19)? en: https://www.frontiersin.org/articles/10.3389/fmicb.2013.00293/full DOI: https://doi.org/10.3389/fmicb.2013.00293
dc.relation/*ref*/Eapen MS, Sharma P, Sohal S. Mitochondrial dysfunction in macrophages: a key to defective bacterial phagocytosis in COPD. Eur Respir J. [Internet]. 2019 oct; 54(4): 1901641. Disponible en: https://erj.ersjournals.com/content/54/4/1901641 DOI: https://doi.org/10.1183/13993003.01641-2019
dc.relation/*ref*/Eapen MS, Sohal SS. Understanding novel mechanisms of microbial pathogenesis in chronic lung disease: Implications for new therapeutic targets. Clin Sci (Lond). [Internet]. 2018 feb; 132(3): 375-379. Disponible en: https://portlandpress.com/clinsci/article-abstract/132/3/375/72102/Understanding-novel-mechanisms-of-microbial?redirectedFrom=fulltext DOI: https://doi.org/10.1042/CS20171261
dc.relation/*ref*/Sohal SS. Inhaled corticosteroids and increased microbial load in COPD: Potential role of epithelial adhesion molecules. Eur Respir J. [Internet]. 2018 ene; 51(2): 1702257. Disponible en: https://erj.ersjournals.com/content/51/2/1702257 DOI: https://doi.org/10.1183/13993003.02257-2017
dc.relation/*ref*/Han L, Ran J, Mak YW, Suen LK, Lee PH, Peiris JSM, et al.Smoking and influenza-associated morbidity and mortality: a systematic Review and meta-analysis. Epidemiology. [Internet]. 2019 may; 30(3): 405- 417. Disponible en: https://journals.lww.com/epidem/Abstract/2019/05000/Smoking_and_Influenza_associated_Morbidity_and.15.aspx DOI: https://doi.org/10.1097/EDE.0000000000000984
dc.relation/*ref*/Mallia P, Message SD, Gielen V, Contoli M, Gray K, Kebadze T, et al.Experimental Rhinovirus Infection as a Human Model of Chronic Obstructive Pulmonary Disease Exacerbation. Am J Respir Crit Care Med. [Internet]. 2011 mar; 183(6): 734-742. Disponible en: https://www.atsjournals.org/doi/full/10.1164/rccm.201006-0833OC DOI: https://doi.org/10.1164/rccm.201006-0833OC
dc.relation/*ref*/Wilkinson T, Donaldson G, Johnston S, Openshaw P, Wedzicha J. Respiratory syncytial virus, airway inflammation, and fev1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. [Internet]. 2006 abr; 173(8): 871-876. Disponible en: https://www.atsjournals.org/doi/full/10.1164/rccm.200509-1489OC DOI: https://doi.org/10.1164/rccm.200509-1489OC
dc.relation/*ref*/Seemungal T, Harper-Owen R, Bhowmik A, Sanderson G, Message S, MacCallum P, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. [Internet]. 2001 nov; 164(9): 1618-1623. Disponible en: https://www. atsjournals.org/doi/full/10.1164/ajrccm.164.9.2105011 DOI: https://doi.org/10.1164/ajrccm.164.9.2105011
dc.relation/*ref*/Papi A, Bellettato CA, Braccioni F, Romagnoli M, Casolari P, Caramori G, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. [Internet]. 2006 may; 173(10): 1114-1121. DOI: https://doi.org/10.1164/rccm.200506-859OC
dc.relation/*ref*/Frickmann H, Jungblut S, Hirche TO, Groß U, Kuhns M, Zautner AE. The influence of virus infections on the course of COPD. Eur J Microbiol Immunol. [Inter- net]. 2012 sept; 2(3): 176-185. Disponible en: https://akjournals.com/view/journals/1886/2/3/article-p176. xml DOI: https://doi.org/10.1556/EuJMI.2.2012.3.2
dc.relation/*ref*/Peiris JSM, Chu CM, Cheng VCC, Chan KS, Hung IFN, Poon LLM, et al. Clinical progression and viral load in a community outbreak of coronavirus-associa- ted SARS pneumonia: a prospective study. Lancet. [Internet]. 2003 may; 361(9371): 1767-1772. DOI: https://doi.org/10.1016/S0140-6736(03)13412-5
dc.relation/*ref*/Memish ZA, Perlman S, Van Kerkhove MD, Zumla A. Middle east respiratory syndrome. Lancet. [Internet]. 2020 mar; 395(10229): 1063-1077. Disponible en: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)33221-0/fulltext DOI: https://doi.org/10.1016/S0140-6736(19)33221-0
dc.relation/*ref*/Lin L, Lu L, Cao W, Li T. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Journal Emerging Microbes & Infections. [Internet]. 2020 dic; 9(1): 727-732. DOI: https://doi.org/10.1080/22221751.2020.1746199
dc.relation/*ref*/Raj VS, Mou H, Smits SL, Dekkers DH, Müller MA, Dijkman R, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-emc. Nature. [Internet]. 2013 mar; 495(7440): 251-254. DOI: https://doi.org/10.1038/nature12005
dc.relation/*ref*/Coutard B, Valle C, Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. [Internet]. 2020 abr; 176: 104742. DOI: https://doi.org/10.1016/j.antiviral.2020.104742
dc.relation/*ref*/Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell rna expression profiling of ace2, the putative receptor of Wuhan 2019-nCov. Am J Respir Crit Care Med. [Internet]. 2020 sept; 202(5): 756-759. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462411/ DOI: https://doi.org/10.1164/rccm.202001-0179LE
dc.relation/*ref*/Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS. Smoking upregulates angiotensin - converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (covid-19). J Clin Med. [Internet]. 2020 mar; 9(3); 841. DOI: https://doi.org/10.3390/jcm9030841
dc.relation/*ref*/Singh AK, Gupta R, Misra A. Comorbidities in covid-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes Metab Syndr. [Internet]. 2020 ago; 14(4): 283- 287. Disponible en: https://www.sciencedirect.com/science/article/pii/S1871402120300564?via%3Dihub DOI: https://doi.org/10.1016/j.dsx.2020.03.016
dc.relation/*ref*/Leung JM, Yang CX, Tam A, Shaipanich T, Hackett TL, Singhera GK, et al. ace-2 expression in the small airway epithelia of smokers and COPD patients: implications for covid-19. Eur Respir J. [Internet]. 2020 may; 55(5): 2000688. Disponible en: https://erj.ersjournals.com/content/55/5/2000688 DOI: https://doi.org/10.1183/13993003.00688-2020
dc.relation/*ref*/Arnold F, Mahmood K, Angeline P, Aden D, Raghu- ram A, Burns MA, et al. COPD exacerbation caused by SARS-CoV-2: a case report from the Louisville covid-19 surveillance program. The Univ Louisville J Respir Infect. [Internet]. 2020; 4(1): artículo 5. Disponible en: https://ir.library.louisville.edu/jri/vol4/iss1/5/
dc.relation/*ref*/Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. [Internet]. 2005 jul; 436(7047): 112-116. Disponible en: https://www.nature.com/articles/nature03712 DOI: https://doi.org/10.1038/nature03712
dc.relation/*ref*/Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. [Internet]. 2020 may; 395(10235): 1517-1520. DOI: https://doi.org/10.1016/S0140-6736(20)30920-X
dc.relation/*ref*/Jones PW, Lamarca R, Chuecos F, Singh D, Agustí A, Bateman ED, et al. Characterisation and impact of reported and unreported exacerbations: results from attain. Eur Resp J. [Internet]. 2014 nov; 44(5): 1156-1165. Disponible en: https://erj.ersjournals.com/content/44/5/1156 DOI: https://doi.org/10.1183/09031936.00038814
dc.relation/*ref*/Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. [Internet]. 1998 may; 157(1): 1418-1422. Disponible en: https://www.atsjournals.org/doi/full/10.1164/ajrccm.157.5.9709032 DOI: https://doi.org/10.1164/ajrccm.157.5.9709032
dc.relation/*ref*/Thomas Y, Boquete-Suter P, Koch D, Pittet D, Kaiser LL. Survival of influenza virus on human fingers. Clin Microbiol Infect. [Internet]. 2014 ene; 20(1): 92-93. Disponible en: https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(14)60219-6/fulltext DOI: https://doi.org/10.1111/1469-0691.12324
dc.relation/*ref*/Kac G, Podglajen I, Gueneret M, Vaupre S, Bissery A, Meyer G. Microbiological evaluation of two hand hygiene procedures achieved by healthcare workers during routine patient care: a randomized study. J Hosp Infect. [Internet]. 2005 may; 60(1): 32-39. DOI: https://doi.org/10.1016/j.jhin.2004.10.014
dc.relation/*ref*/Zhou SS, Lukula S, Chiossone C, Nims RW, Suchmann DB, Ijaz MK. Assessment of a respiratory face mask for capturing air pollutants and pathogens including human influenza and rhinoviruses. J Thorac Dis. [Internet]. 2018 mar 10(3): 2059- 2069. Disponible en: https://jtd.amegroups.com/article/view/20136/15564 DOI: https://doi.org/10.21037/jtd.2018.03.103
dc.relation/*ref*/Ma QX, Shan H, Zhang HL, Li GM, Yang RM, Chen JM. Potential utilities of mask‐wearing and instant hand hygiene for fighting SARS-CoV-2. J Med Virol. [Internet]. 2020 sept; 92(9): 1567-1571. Disponible en: https://onlinelibrary.wiley.com/doi/10.1002/jmv.25805 DOI: https://doi.org/10.1002/jmv.25805
dc.relation/*ref*/McManus TE, Coyle PV, Kidney JC. Childhood respiratory infections and hospital admissions for copd. Resp Med. [Internet]. 2006 mar; 100(3): 512-518. DOI: https://doi.org/10.1016/j.rmed.2005.06.001
dc.relation/*ref*/Greenberg SB. Viral respiratory infections in elderly patients and patients with chronic obstructive pulmonary disease. Am J of Med. [Internet]. 2002 abr; 112(6): 28-32. DOI: https://doi.org/10.1016/S0002-9343(01)01061-0
dc.relation/*ref*/Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med. [Internet]. 1996 sept; 154(3): 654-660. Disponible en: https://www.atsjournals.org/doi/abs/10.1164/ajrccm.154.3.8810601 DOI: https://doi.org/10.1164/ajrccm.154.3.8810601
dc.relation/*ref*/Mannino D, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc. [Internet]. 2007 oct; 4(7): 502- 506. Disponible en: https://pats.atsjournals.org/cgi/doi/10.1513/pats.200701-001FM DOI: https://doi.org/10.1513/pats.200701-001FM
dc.relation/*ref*/Celli BR, MacNee W, Agusti A, Anzueto A, Berg B, Buist AS, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ats/ers position paper. Eur Respir J. [Internet]. 2004 jun; 23(6): 932-946. Disponible en: https://erj.ersjournals.com/content/23/6/932 DOI: https://doi.org/10.1183/09031936.04.00014304
dc.relation/*ref*/Toy EL, Gallagher KF, Stanley EL, Swensen AR, Duh MS. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD [Internet]. 2010 jun; 7(3): 214-28. Disponible en: https://www.tandfonline.com/doi/abs/10.3109/15412555.2010.481697?journalCode=icop20 DOI: https://doi.org/10.3109/15412555.2010.481697
dc.relation/*ref*/Simoens S, Decramer M, De Coster S, Celis G, Laekeman G. Clinical and economic analysis of antimicrobial therapy of chronic obstructive pulmonary disease exacerbations. Int J Clin Pract. [Internet]. 2007 feb; 61(2): 200-206. Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/j.1742-1241.2006.01240.x DOI: https://doi.org/10.1111/j.1742-1241.2006.01240.x
dc.relation/*ref*/O'Reilly JF, Williams AE, Rice L. Health status impairment and costs associated with COPD exacerbation managed in hospital. Int J Clin Pract. [Internet]. 2007 jul; 61(7): 1112-1120. DOI: https://doi.org/10.1111/j.1742-1241.2007.01424.x
dc.relation/*ref*/Mittmann N, Kuramoto L, Seung SJ, Haddon JM, Bradley-Kennedy C, FitzGerald JM. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med. [Internet]. 2008 mar; 102(3): 413-421. DOI: https://doi.org/10.1016/j.rmed.2007.10.010
dc.relation/*ref*/Oostenbrink JB, Rutten-van-Molken MPM. Resource use and risk factors in high-cost exacerbations of COPD. Respir Med. [Internet]. 2004 sept; 98(9): 883-891. Disponible en: https://www.resmedjournal.com/article/S0954-6111(04)00082-4/fulltext DOI: https://doi.org/10.1016/j.rmed.2004.02.013
dc.rightsDerechos de autor 2022 Revista Medes-ES
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0es-ES
dc.sourceRevista Med; Vol. 29 No. 2 (2021): july - december; 65-78en-US
dc.sourceRevista Med; Vol. 29 Núm. 2 (2021): julio - diciembre; 65-78es-ES
dc.source1909-7700
dc.source0121-5256
dc.titleImportance of Viruses in Exacerbations of Chronic Obstructive Pulmonary Disease (COPD). Could Change its Behavior During the SARS-COV-2 (COVID-19) pandemic?en-US
dc.titleImportancia de los virus en las exacerbaciones de Enfermedad Pulmonar Obstructiva Crónica (EPOC). ¿Podría cambiar su comportamiento durante la pandemia de SARS-COV-2 (COVID-19)?es-ES
dc.titleImportância dos vírus nas exacerbações da Doença Pulmonar Obstrutiva Crônica (DPOC). Poderia mudar seu comportamento durante a pandemia de SARS-COV-2 (COVID-19)?pt-BR
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución